A1J84E
AbbVie, Inc. · LSX:A1J84E
262.90 EUR−0.3000 −0.11%
AbbVie, Inc. (LSX:A1J84E) last traded at 262.90 EUR, down 0.11% on the day. Over the past year the stock is up 34.41%. Its 52-week range is 163.40 to 266.80. It is in the Health Technology sector (Pharmaceuticals: Major).
Key statistics
Open264.60
Day range262.90 – 264.60
52-week range163.40 – 266.80
Volume5
Average volume (10 days)60
Market cap (USD)521.11 B
P/E51.19
EPS (TTM) (USD)5.82
Dividend yield2.32%
Beta (1 year)0.0129
Revenue (TTM) (USD)66.01 B
Employees57.00 K
Performance
+2.90%1 week
+14.01%1 month
+23.02%3 months
+49.80%6 months
+35.38%Year to date
+34.41%1 year
Technical reading
Bullish
Daily summary of what 11 oscillators and 15 moving averages show. See every indicator
Latest headlines
- Canaccord Genuity maintains AbbVie at Buy, raises price target to $338 from $290TradingView · 02 Nov 2026
- AbbVie Is Maintained at Overweight by Cantor FitzgeraldDow Jones Newswires · 02 Nov 2026
- Cantor Fitzgerald maintains AbbVie at Overweight, raises price target to $325 from $290TradingView · 02 Nov 2026
- Weekly Recap: Q3 financial gains and Skyrizi Crohn’s FDA approvalTradingView · 02 Nov 2026
- The top 5 analyst questions from AbbVie’s Q3 earnings callStock Story · 01 Nov 2026
- Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growthSeeking Alpha · 31 Oct 2026
- Key facts: AbbVie, Inc. Q3 revenue $17.404B; Skyrizi approved; lutikizumab successTradingView · 31 Oct 2026
- ABBV Q3 deep dive: Immunology and neuroscience drive growth, pipeline progress continuesStock Story · 31 Oct 2026
Market data from TradingView’s public feed, delayed as the exchange requires. SuperCharting is charting software and gives no investment advice.